In-vitro Assessments of Clot Elicitation by Thrombogenic Fibers vs. Embolization Coils.
Journal
ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109
Informations de publication
Date de publication:
01 10 2022
01 10 2022
Historique:
entrez:
4
10
2022
pubmed:
5
10
2022
medline:
7
10
2022
Statut:
ppublish
Résumé
Late and persistent type II endoleaks (EL2) following Endovascular Aneurysm Repair (EVAR) have been recognized as an independent and significant risk factor for aneurysm sac growth and secondary procedures. Solutions are available for treatment, with varying success rates; preventive perioperative sac embolization with coils appears safe and effective. The objective of this study is to compare whole blood coagulation elicited by a textile stent-graft equipped with thrombogenic, patented "Kardiozis" fibers (PKF) to that elicited by embolization coils in an in vitro study. The approach is to establish an equivalence between PKF and coils in a static model, then to compare clot elicitation by both materials in a perfused model aneurysm chamber subjected to EL2. The weight of clot elicited during exposure to blood was the primary measurement. In the static model, PKF and coils were soaked in blood for up to 90 minutes (N = 30) and elicited similar clotting. In the dynamic model, stent-grafts equipped with PKF or coils were exposed to blood flow inside an aneurysm model for up to 3h (N = 5), with generally higher clot weights for stent-grafts with PKF (non-significant). Complete thrombosis of the aneurysm model was observed in one experimental series (positive control and stent-graft with PKF). A stent-graft with PKF elicits at least as much clot as embolization coils dispersed in an aneurysm model chamber under continuous blood flow. PKF positioned on the outer wall of stent-grafts could have a similar action as coiling of the aneurysm sac during the index EVAR.
Identifiants
pubmed: 36194096
doi: 10.1097/MAT.0000000000001645
pii: 00002480-202210000-00008
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1256-1262Informations de copyright
Copyright © ASAIO 2022.
Références
Patel R, Powell JT, Sweeting MJ, Epstein DM, Barrett JK, Greenhalgh RM: The UK EndoVascular Aneurysm Repair (EVAR) randomised controlled trials: long-term follow-up and cost-effectiveness analysis. Health Technol Assess 22: 1–132, 2018.
Abularrage CJ, Patel VI, Conrad MF, Schneider EB, Cambria RP, Kwolek CJ: Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair. J Vasc Surg 56: 630–636, 2012.
Jouhannet C, Alsac JM, Julia P, et al.: Reinterventions for type 2 endoleaks with enlargement of the aneurismal sac after endovascular treatment of abdominal aortic aneurysms. Ann Vasc Surg 28: 192–200, 2014.
Ultee KHJ, Büttner S, Huurman R, et al.: Editor’s choice - systematic review and meta-analysis of the outcome of treatment for type II endoleak following endovascular aneurysm repair. Eur J Vasc Endovasc Surg 56: 794–807, 2018.
Chew DK, Dong S, Schroeder AC, Hsu HW, Franko J: The role of the inferior mesenteric artery in predicting secondary intervention for type II endoleak following endovascular aneurysm repair. J Vasc Surg 70: 1463–1468, 2019.
Bianchini Massoni C, Perini P, Fanelli M, et al.: Intraoperative contrast-enhanced ultrasound for early diagnosis of endoleaks during endovascular abdominal aortic aneurysm repair. J Vasc Surg 70: 1844–1850, 2019.
Gonzalez-Urquijo M, Lozano-Balderas G, Fabiani MA: Type II endoleaks after EVAR: a literature review of current concepts. Vasc Endovascular Surg 54: 718–724, 2020.
Cieri E, De Rango P, Isernia G, et al.: Type II endoleak is an enigmatic and unpredictable marker of worse outcome after endovascular aneurysm repair. J Vasc Surg 59: 930–937, 2014.
Veith FJ, Baum RA, Ohki T, et al.: Nature and significance of endoleaks and endotension: summary of opinions expressed at an international conference. J Vasc Surg 35: 1029–1035, 2002.
Makaroun M, Zajko A, Sugimoto H, Eskandari M, Webster M: Fate of endoleaks after endoluminal repair of abdominal aortic aneurysms with the EVT device. Eur J Vasc Endovasc Surg 18: 185–190, 1999.
Schanzer A, Greenberg RK, Hevelone N, et al.: Predictors of abdominal aortic aneurysm sac enlargement after endovascular repair. Circulation 123: 2848–2855, 2011.
Zhou W, Blay E Jr, Varu V, et al.: Outcome and clinical significance of delayed endoleaks after endovascular aneurysm repair. J Vasc Surg 59: 915–920, 2014.
Chaikof EL, Dalman RL, Eskandari MK, et al.: The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg 67: 2–77.e2, 2018.
Wanhainen A, Verzini F, Van Herzeele I, et al.: Editor’s Choice – European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg 57: 8–93, 2018.
Leyon JJ, Littlehales T, Rangarajan B, Hoey ET, Ganeshan A: Endovascular embolization: review of currently available embolization agents. Curr Probl Diagn Radiol 43: 35–53, 2014.
Sarac TP, Gibbons C, Vargas L, et al.: Long-term follow-up of type II endoleak embolization reveals the need for close surveillance. J Vasc Surg 55: 33–40, 2012.
Brown A, Saggu GK, Bown MJ, Sayers RD, Sidloff DA: Type II endoleaks: challenges and solutions. Vasc Health Risk Manag 12: 53–63, 2016.
Fabre D, Fadel E, Brenot P, et al.: Type II endoleak prevention with coil embolization during endovascular aneurysm repair in high-risk patients. J Vasc Surg 62: 1–7, 2015.
Piazza M, Squizzato F, Zavatta M, et al.: Outcomes of endovascular aneurysm repair with contemporary volume-dependent sac embolization in patients at risk for type II endoleak. J Vasc Surg 63: 32–38, 2016.
Mascoli C, Freyrie A, Gargiulo M, et al.: Selective Intra-procedural AAA sac embolization during EVAR reduces the rate of type II endoleak. Eur J Vasc Endovasc Surg 51: 632–639, 2016.
Ferretto L, Irsara S: Totally percutaneous aneurysm sac embolization during endovascular aneurysm repair. J Endovasc Ther 24: 68–71, 2017.
Fabre D, Mougin J, Mitilian D, et al.: Prospective, randomised two centre trial of endovascular repair of abdominal aortic aneurysm with or without sac embolisation. Eur J Vasc Endovasc Surg 61: 201–209, 2021.
Dosluoglu HH, Rivero M, Khan SZ, Cherr GS, Harris LM, Dryjski ML: Pre-emptive nonselective perigraft aortic sac embolization with coils to prevent type II endoleak after endovascular aneurysm repair. J Vasc Surg 69: 1736–1746, 2019.
Natrella M, Rapellino A, Navarretta F, et al.: Embo-EVAR: a technique to prevent type II endoleak? A single-center experience. Ann Vasc Surg 44: 119–127, 2017.
Sukavaneshvar S: Device thrombosis and pre-clinical blood flow models for assessing antithrombogenic efficacy of drug-device combinations. Adv Drug Deliv Rev 112: 24–34, 2017.
Kocsis JF, Llanos G, Holmer E: Heparin-coated stents. J Long Term Eff Med Implants 10: 19–45, 2000.
Lotito M, Sukavaneshvar S, Olsen D, et al.: Thromboresistance provided by a heparin coating on the Tal PALINDROME EMERALD hemodialysis catheter in 39th Annual Meeting of American Society of Nephrology. 2006.
Girdhar G, Read M, Sohn J, Shah C, Shrivastava S: In-vitro thrombogenicity assessment of polymer filament modified and native platinum embolic coils. J Neurol Sci 339: 97–101, 2014.
Trerotola SO, Pressler GA, Premanandan C: Nylon fibered versus non-fibered embolization coils: Comparison in a swine model. J Vasc Interv Radiol 30: 949–955, 2019.
Henkes H, Brew S, Felber S, et al.: In vitro and in vivo studies of the extent of electrothrombotic deposition of blood elements on the surface of electrolytically detachable coils. Interv Neuroradiol 10: 189–201, 2004.
Liebig T, Henkes H, Fischer S, et al.: Fibered electrolytically detachable platinum coils used for the endovascular treatment of intracranial aneurysms. Initial experiences and mid-term results in 474 aneurysms. Interv Neuroradiol 10: 5–26, 2004.
Lalys F, Daoudal A, Gindre J, Göksu C, Lucas A, Kaladji A: Influencing factors of sac shrinkage after endovascular aneurysm repair. J Vasc Surg 65: 1830–1838, 2017.
Sheehan MK, Hagino RT, Canby E, et al.: Type 2 endoleaks after abdominal aortic aneurysm stent grafting with systematic mesenteric and lumbar coil embolization. Ann Vasc Surg 20: 458–463, 2006.
Kray J, Kirk S, Franko J, Chew DK: Role of type II endoleak in sac regression after endovascular repair of infrarenal abdominal aortic aneurysms. J Vasc Surg 61: 869–874, 2015.
Jaffer IH, Fredenburgh JC, Hirsh J, Weitz JI: Medical device-induced thrombosis: what causes it and how can we prevent it? J Thromb Haemost 13(suppl 1): S72–S81, 2015.
Kolandaivelu K, Swaminathan R, Gibson WJ, et al.: Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation 123: 1400–1409, 2011.
Prasad S, Kashyap RS, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF: Development of an in vitro model to study clot lysis activity of thrombolytic drugs. Thromb J 4: 14, 2006.
Smith RS, Zhang Z, Bouchard M, et al.: Vascular catheters with a nonleaching poly-sulfobetaine surface modification reduce thrombus formation and microbial attachment. Sci Transl Med 4: 153ra132, 2012.
Zhang Z, Borenstein J, Guiney L, Miller R, Sukavaneshvar S, Loose C: Polybetaine modification of PDMS microfluidic devices to resist thrombus formation in whole blood. Lab Chip 13: 1963–1968, 2013.